Apposite Capital said Tuesday it has appointed Anne-Laure Meynier as Investment Manager. Meynier was most recently CFO of Nuage Labs, a Paris based technology start-up.
London, UK – 10 November 2015. Apposite Capital, the private equity firm specialising in healthcare, today announces that it has appointed Anne-Laure Meynier as Investment Manager. She will work with the Apposite Partners in originating, executing and managing investments.
Anne-Laure brings over 5 years of experience in private equity and M&A. She started her career in 2009 within the healthcare M&A team at Rothschild Global Financial Advisory group where she worked on a number of high profile deals in the European healthcare sector. In 2013 she joined Bridgepoint as an Executive in the investment team and was focused on investment execution and due diligence. She was most recently CFO of Nuage Labs, a Paris based technology start-up, where she managed fundraising activities and the finance function.
David Porter, Managing Partner at Apposite Capital, commented: “We are delighted to welcome Anne-Laure to the Apposite team. With a number of new deals in the pipeline, her experience will be very valuable in assisting us to move some of these deals forwards.”
– END –
About Apposite Capital
Apposite Capital is an independent investment firm focused exclusively on healthcare.
The firm operates at the small end of the private equity market, providing both capital and expertise to those businesses offering ‘disruptive’ models that aim to improve or reduce the cost of care provision and which have the potential of becoming market leaders.
Apposite has an in-depth sector knowledge covering key aspects of the healthcare industry internationally coupled with local insights, an exceptional network and an entrepreneurial mindset which it applies to drive the growth of its portfolio companies.
Apposite was created in 2006 and is headquartered in London, UK.